Cangrelor Reduces Procedural Complications and Should Be the Default Strategy
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Chiesi; Abbott Vascular; Abiomed; Pfizer